期刊文献+

In advanced pancreatic cancer: The value and significance of interventional therapy 被引量:4

下载PDF
导出
摘要 Pancreatic cancer is famous as“the king of cancer”due to its high degree of malignancy,rapid course of disease development,and poor prognosis.Relevant epidemiological studies have indicated that with improvement in people’s standard of living,the morbidity and mortality of pancreatic cancer has increased.At the same time,the disease shows an obvious upward trend worldwide.Pancreatic cancer has become a major public health problem that seriously affects the life and health of people.The present review focuses on the recent advances in interventional therapy such as transcatheter arterial infusion,radiofrequency ablation,microwave ablation,and irreversible electroporation of pancreatic cancer.
出处 《Journal of Interventional Medicine》 2020年第3期118-121,共4页 介入医学杂志(英文)
  • 相关文献

参考文献3

二级参考文献27

  • 1Nicolas C Buchs,Michael Chilcott,Pierre-Alexandre Poletti,Leo H Buhler,Philippe Morel.Vascular invasion in pancreatic cancer:Imaging modalities,preoperative diagnosis and surgical management[J].World Journal of Gastroenterology,2010,16(7):818-831. 被引量:29
  • 2Inal A, Kos F'F, Algin E, et al. Prognostic factors for gemcitabine-refraetory patients with advanced pancreatic cancer: a retrospective analysis of a multicenter study ( Anatolian Society of Medical Oncology) [J]. Contemp Oncol (Pozn), 2015, 19(2) : 125-129. DOI: 10. 5114/wo. 2014. 43933.
  • 3Mailer MW, Friess H, Kninger J, et al. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas [ J]. Am J Surg, 2008, 195 : 221- 228.
  • 4Gleisner AL, Assumpcao L, Cameron JL, et al. Is resection of periampullary or pancreatic adenocarcinoma with synchronous hepatic metastasis justified? [ J]. Cancer, 2007, 110( 11 ) :2484- 2492.
  • 5Ouyang H, Wang P, Meng Z, et al. Muhimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine[ J]. Pancreas, 2011, 40 ( 1 ) : 120-125. DOI: 10. 1097/ MPA. 0b013e3181 e6e398.
  • 6Tawada K, Ishihara T, Kobayashi A, et al. Quantitative analysis of vascular endothelial growth factor in liver metastases from pancreatic carcinoma as a predictor of chemotherapeutic effect and prognosis[J]. Clin Cancer Res,2008, 14(22):7438-7443. DOI: 10. 1158/1078-0432. CCR-07-4980.
  • 7Nentwich MF, Bockhorn M, Knig A, et al. Surgery for advanced and metastatic pancreatic cancer--current state and trends [ J]. Anticancer Res ,2012, 32 ( 5 ) : 1999-2002.
  • 8Shrikhande SV, Kleeff J, Reiser C, et al. Pancreatic resection for M1 pancreatic ductal adenocarcinon]a [ J]. Ann Surg Oncol, 2007, 14(1) :118-127.
  • 9Zhang DS, Wang DS, Wang ZQ, et al. Phase I/II study of albumin-bound nab-paclitaxel plus gemcitabine administered to Chinese patients with advanced pancreatic cancer [ J]. Cancer Chemother Pharmacol, 2013, 71 (4) :1065-1072. DOI: 10. 1007/ s00280-013-2102-4.
  • 10Cunningham D, Chan I, Stocken DD, et al. Phase III randomized comparison of gemcitabine versus gemcitabine plus capecitabine in patients with advanced pancreatic cancer [ J]. J Clin Oncol, 2009, 27(33) :5513-5518. DOI: 10. 1200/JCO. 2009.24. 2446.

共引文献21

同被引文献36

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部